Current filters:
Add Filter:


Customise results display
Item hits:
Issue DateTitleAuthor(s)
2016-01The potential and value of epidemiology in curbing non-communicable diseases.Patel, A; Webster, R
2019-01The role of context in implementation research for non-communicable diseases: Answering the 'how-to' dilemma.Daivadanam, M; Ingram, M; Sidney Annerstedt, K; Parker, G; Bobrow, K; Dolovich, L; Gould, G; Riddell, M; Vedanthan, R; Webster, J; Absetz, P; Mölsted Alvesson, H; Androutsos, O; Chavannes, N; Cortez, B; Devarasetty, P; Fottrell, E; Gonzalez-Salazar, F; Goudge, J; Herasme, O; Jennings, H; Kapoor, D; Kamano, J; Kasteleyn, MJ; Kyriakos, C; Manios, Y; Mogulluru, K; Owolabi, M; Lazo-Porras, M; Silva, W; Thrift, A; Uvere, E; Webster, R; van der Kleij, R; van Olmen, J; Vardavas, C; Zhang, P; GACD Concepts and Contexts working group
2015-11-09Behaviour change strategies for reducing blood pressure-related disease burden: findings from a global implementation research programme.GACD Hypertension Research Programme, Writing Group; Peiris, D; Thompson, SR; Beratarrechea, A; Cárdenas, MK; Diez-Canseco, F; Goudge, J; Gyamfi, J; Kamano, JH; Irazola, V; Johnson, C; Kengne, AP; Keat, NK; Miranda, JJ; Mohan, S; Mukasa, B; Ng, E; Nieuwlaat, R; Ogedegbe, O; Ovbiagele, B; Plange-Rhule, J; Praveen, D; Salam, A; Thorogood, M; Thrift, AG; Vedanthan, R; Waddy, SP; Webster, J; Webster, R; Yeates, K; Yusoff, K; Hypertension Research Programme members
2019-07-16Process evaluation in the field: global learnings from seven implementation research hypertension projects in low-and middle-income countries.Limbani, F; Goudge, J; Joshi, R; Maar, MA; Miranda, JJ; Oldenburg, B; Parker, G; Pesantes, MA; Riddell, MA; Salam, A; Trieu, K; Thrift, AG; Van Olmen, J; Vedanthan, R; Webster, R; Yeates, K; Webster, J; Global Alliance for Chronic Diseases, Process Evaluation Working Group
2012-01The efficacy and tolerability of 'polypills': meta-analysis of randomised controlled trials.Elley, CR; Gupta, AK; Webster, R; Selak, V; Jun, M; Patel, A; Rodgers, A; Thom, S
2019-02Fixed-dose combination medications for non-communicable diseases.Webster, R
2010-01Perceptions of risk: understanding cardiovascular disease.Webster, R; Heeley, E
2019-09Barriers and Facilitators to the Use of Cardiovascular Fixed-Dose Combination Medication (Polypills) in Andhra Pradesh, India: A Mixed-Methods Study.Salam, A; Praveen, D; Patel, A; Tewari, A; Webster, R
2016-03-29Pragmatic Trials for Noncommunicable Diseases: Relieving Constraints.Patel, A; Webster, R
2011-01An international randomised placebo-controlled trial of a four-component combination pill ("polypill") in people with raised cardiovascular risk.PILL Collaborative Group; Rodgers, A; Patel, A; Berwanger, O; Bots, M; Grimm, R; Grobbee, DE; Jackson, R; Neal, B; Neaton, J; Poulter, N; Rafter, N; Raju, PK; Reddy, S; Thom, S; Vander Hoorn, S; Webster, R
Results 1-10 of 14 (Search time: 0.049 seconds).